Connect with us

Science

Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU) – PRNewswire

/PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology…

CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publication of two papers in the journals Nature Metabolism…

Click here to view the original article.

You might also like ...

Article feature image
Astronomers discover how to feed a black hole – Science Daily
Article feature image
NASA shares staggering footage of ‘Coronal Mass Ejection’ on sun at 16,00,000 km per hour – Republic World